Echosens and Novo Nordisk A/S announced a partnership to advance early diagnosis of non-alcoholic steatohepatitis (NASH) and increase awareness of the disease among patients, healthcare providers, and other stakeholders.
[Echosens]
Home Newsletters Hepatic Cell News Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early...
